* UI Enhancements
* Bug fixes
30 Day Free Trial
** Featuring Latest Updates**
** Trusted by Health Care Professionals for Over 30 Years **
ABOUT MOSBY’S DRUG REFERENCE
Based on the latest 2022 edition, Mosby’s Drug Reference provides health care professionals with the tools they need to eliminate errors and improve accuracy. Drug monographs feature concise, easy-to-understand information and make finding answers easy with sections on each drug’s action, usage, dosage, interactions, side effects, and more. Download this powerful drug resource to your smartphone or tablet for easy access in the classroom or at the point of care.
FEATURES
• Detailed monographs for more than 5,000 generic and trade-name drugs
• Appendix of recent FDA-approvals
• Icons for High Alert and Rarely Used medications
• Highlighted Black Box Warnings, safety alerts, and life-threatening side effects
• Helpful IV therapy updates
• Highlight and make custom notes within entries
• Create custom notes and highlights within entries
• 150+ abbreviations listed for practical understanding
• Unlabeled uses and easily confused drug names
• Full Text Search help find medications quickly
• “Favorites” for bookmarking important entries
FREE 30-DAY TRIAL: WHAT TO EXPECT
• First-time users can access Unbound's complete Mosby's Drug Reference mobile app free for 30 days
• After 30 days, your Google Play account will be charged $45.99 for a one-year subscription unless you have turned off auto-renew at least 24 hours before the free trial ends.
•NOTE: If you choose not to purchase a subscription, content will no longer be viewable after the free trial period.
Authors: Linda Skidmore-Roth, RN, MSN, NP
Publisher: Elsevier
Powered by: Unbound Medicine
Unbound Privacy Policy: www.unboundmedicine.com/privacy
Unbound Terms of Use: https://www.unboundmedicine.com/end_user_license_agreement